Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Hydrocortisone Acetate 2.5%/Neomycin 3.5 mg/Gm Topical Cream is a compounded, semisolid preparation. It is dispensed via a pump mechanism for convenient and controlled application on the skin.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Hydrocortisone Acetate 2.5%/Neomycin 3.5 mg/Gm Topical Cream is a specially compounded medication designed to treat a wide range of skin conditions. This unique formulation combines the anti-inflammatory properties of hydrocortisone acetate with the antibacterial benefits of neomycin. Additionally, it can be used to treat bacterial skin infections, including impetigo and folliculitis.
This topical cream is dispensed in a pump mechanism, which allows for convenient and controlled application directly onto the skin. This ensures that the active ingredients are localized to the area of treatment, maximizing their effectiveness while minimizing potential side effects. It is crucial to follow the directions provided by your healthcare provider when using this medication to ensure optimal results.
While generally well-tolerated, some users may experience side effects such as skin irritation, burning, or itching. If you experience any of these symptoms, or any other adverse reactions, it is important to contact your healthcare provider immediately. They can provide guidance and, if necessary, adjust your treatment plan.
As with any medication, it is important to use it as directed by your healthcare provider. If you have any questions or concerns about this formulation, please do not hesitate to reach out to us at Bayview Pharmacy. We are here to assist you with your healthcare needs.
This compounded formulation of Hydrocortisone Acetate 2.5%/Neomycin 3.5 mg/Gm Topical Cream is a semisolid preparation dispensed in a pump mechanism, designed for convenient and controlled application on the skin. It is primarily used for the treatment of mild to moderate inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Patients are advised to use this formulation as directed by their healthcare provider and to avoid contact with the eyes. In case of accidental contact, the eyes should be thoroughly flushed with water. It is also recommended to avoid using this formulation on the face, groin, or axillae, and to use it for the shortest duration necessary to achieve the desired therapeutic effect.
Regular monitoring for signs of systemic absorption is crucial. This includes looking out for symptoms of adrenal suppression, Cushing's syndrome, and hyperglycemia. Patients should also be vigilant for signs of local irritation, such as burning, itching, dryness, and redness.
Prescribers should be aware of potential interactions of this formulation with other topical medications, including antifungals, antibiotics, and other corticosteroids. Additionally, this formulation may interact with systemic medications, including anticoagulants, diuretics, and oral contraceptives. Therefore, a thorough review of the patient's current medication regimen is necessary before prescribing this formulation.
If you have any questions or concerns about this formulation or its potential interactions, please do not hesitate to reach out for further information.
Hydrocortisone Acetate 2.5%/Neomycin 3.5 mg/Gm Topical Cream is a compounded formulation designed to treat a variety of skin conditions. This medication combines the anti-inflammatory properties of hydrocortisone acetate, a corticosteroid, with the antibacterial action of neomycin, an antibiotic. The hydrocortisone acetate works to alleviate inflammation and irritation on the skin, while the neomycin targets and eliminates bacteria that can lead to infection.
It is dispensed in a semisolid preparation via a pump mechanism, which allows for convenient and controlled application on the skin for localized treatment or absorption of the active ingredients.
When using Hydrocortisone Acetate 2.5%/Neomycin 3.5 mg/Gm Topical Cream, it is crucial to adhere to the instructions provided by your healthcare provider. The cream should be applied to the affected skin area as directed. Prior to application, ensure your hands are clean to prevent further infection. Avoid applying the cream on broken or irritated skin. Unless instructed by your healthcare provider, do not cover the treated area with a bandage or any other covering.
For optimal results, it is important to use Hydrocortisone Acetate 2.5%/Neomycin 3.5 mg/Gm Topical Cream for the full course of treatment as prescribed by your healthcare provider. Discontinuing the medication before the end of the prescribed course, even if symptoms improve, may not fully treat the condition and could lead to its recurrence. If you have any questions or concerns about the use of this medication, consult your healthcare provider for guidance.
This is a compounded formulation of two active ingredients, Hydrocortisone Acetate and Neomycin. It is a semisolid preparation designed for convenient and controlled application on the skin for localized treatment or absorption of these active ingredients.
The pump mechanism is designed for convenient and controlled application of the cream. It allows for precise dosing and minimizes waste or overuse of the product.
This cream should be applied topically to the affected area as directed by your healthcare provider. It is not intended for oral, ophthalmic, or intravaginal use.
Hydrocortisone Acetate is a corticosteroid that can reduce inflammation, redness, and swelling. Neomycin is an antibiotic that can prevent or treat bacterial infections. This cream is often used to treat skin conditions that involve inflammation and/or bacterial infections.
As with any medication, side effects can occur. These may include skin irritation, burning, itching, or dryness. If these side effects persist or worsen, contact your healthcare provider immediately.
Before using this cream, inform your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding. They will be able to advise you on whether this medication is safe for you to use.
Unless directed by your healthcare provider, it is generally not recommended to use this cream on the face, near the eyes, or on other sensitive areas of the body.
If you miss a dose, apply it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not apply extra cream to make up for a missed dose.
Before starting any new medication, including over-the-counter drugs and supplements, inform your healthcare provider if you are using this cream. They will be able to advise you on potential interactions.
This cream should be stored at room temperature, away from heat and direct light. Do not freeze. Keep out of the reach of children and pets.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
